期刊文献+

脑梗死与颈动脉斑块及血脂的相关性分析 被引量:10

Study on the correlation among cerebral infarction,carotid atherosclerotic plaque and plasma lipoprotein
下载PDF
导出
摘要 目的:探讨脑梗死与颈动脉粥样硬化斑块及血脂代谢的关系。方法:对70例脑梗死患者(病例组)和38名正常体检者(对照组)行动脉彩色多普勒超声检查颈动脉硬化斑块,同时检测两组的血浆脂质代谢水平,包括总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)和脂蛋白(a)[LP(a)]。结果:病例组70例,斑块检出率70.0%(49/70),明显高于对照组的18.4%(7/38)(P<0.01);同时比较两组的TC、TG、HDL-C、LDL-C和LP(a)水平。脑梗死组血浆TC、LDL-C水平高于对照组(P<0.05),其它血脂指标无显著差异,而LDL-C/HDL-C比值在两组有明显差异(P<0.01)。将病例组按颈动脉斑块的有无分为脑梗死+斑块组(CI+P)、脑梗死无斑块组(CI-P),发现CI+P组LDL- C、HDL-C较CI-P组分别有升高、下降趋势,但各自差异无显著统计学意义,而研究LDL-C/HDL-C比值则CI+P组明显高于CI-P组(P<0.05)。结论:脑梗死发病与颈动脉粥样硬化斑块密切相关;高血浆TC、LDL-C水平促发脑梗死的发生,分析LDL-C/HDL-C水平与脑梗死的发生有很大的相关性,尤其对有颈动脉粥样斑块的脑梗死有重要意义。 Objective:To study the correlation among cerebral infarction,carotid atherosclerotic plaque and plasma lipopro- tein.Methods:The carotid atherosclerotic plaque was performed with color doppler ultrasonography and the plasma lipoprotein was measured in 70 patients with cerebral infarction (CI) and 38 cases of controls matched in sex and age.CI patients were divided into two groups:cerebral infarction with plaque group (CI+P,n=49) and cerebral infarction without plaque group (CI- P,n=21).Results:(1) The incid...
出处 《南通大学学报(医学版)》 2008年第4期279-280,283,共3页 Journal of Nantong University(Medical sciences)
关键词 脑梗死 颈动脉斑块 血脂 Cerebral infarction Carotid atherosclerotic plaque Plasma lipoprotein
  • 相关文献

参考文献12

  • 1[1]Ben-Haim S,Israel O.PET/CT for atherosclerotic plaque imaging[J].QJ Nucl Med Mol Imaging,2006,50 (1):53-60.
  • 2[2]Jensen LO,Thayssen P,Pedersen KE,et al.Regression of coronary atherosclerosis by simvastatin:a serial intravascular ultrasound study[J].Circulation,2004,110 (3):265-270.
  • 3[3]Ohashi R,Mu H,Yao Q,et al.Atherosclerosis:immunopathogenesis and immunotherapy[J].Med Sci Monit,2004,10 (11):RA255-RA260.
  • 4[4]Mofidi R,Crotty TB,mcCarthy P,et al.Association between plaque instability angiogenesis and symptomatic carotid occlusive disease[J].Br J Surg,2001,88 (7):945-950.
  • 5[5]Davidson MH.Overview of prevention and treatment of atherosclerosis with ipid-altering therapy for pharmacy directors[J].Am J Manag Care.,2007,13 (10):S260-269.
  • 6[6]Teramoto T,Sasaki J,Ueshima H,et al.Diagnostic criteria for dyslipidemia-executive summary of japan atherosclerosis society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for japanese[J].J Atherosclerosis and Thrombosis,2007,14 (4):155-158.
  • 7[7]Rauch U,Osende JI,Fuster V,et al.Thrombus formation on atherosclerotic plaques:pathogenesis and clinical consequences[J].Ann Intern Med,2001,134 (3):224-238.
  • 8[8]Weissberg PL.Atherogenesis:current understanding of the causes of atheroma[J].Heart,2000,83 (2):247-252.
  • 9[9]Simionescu M.Implications of early structural-functional changes in the endothelium for vascular disease[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2007,27 (2):266-274.
  • 10[10]Ritz E,Wanne C.Lipid Changes and Statins in Chronic renal insufficiency[J].J Am Soc Nephrol,2006,17 (12):S226-230.

同被引文献80

引证文献10

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部